Photo courtesy of ICICI Prudential Life Insurance

ICICI Prudential posts 27.8% VBN growth for 2023

Its profitability reached R27.5b.

ICICI Prudential Life Insurance ended their fiscal year with a Value of New Business (VNB) growth of 27.8% to R27.6b. 

The VNB – an indicator of profitability – had a margin growth of 32% year-on-year (YoY) for the fiscal year ending March 2023.

The substantial growth in VNB over the four-year span has been propelled by the efficacious execution of the 4P strategy, which encompasses augmenting Premium and Protection business growth, enhancing Persistency, and boosting Productivity while maintaining a customer-centric approach. 

ALSO READ: Outstanding insurers recognised at the 7th Insurance Asia Awards

Moreover, the integration of Environmental, Social, and Governance (ESG) factors into business management has also played a pivotal role in driving VNB growth.

The company’s annualised premium equivalent (APE) – a measure of new business – expanded 11.7% YoY to R86.4b. Protection APE also jumped 14.5% YoY to R15.0b. Whilst the new business total assured went up by 34.7% to R10.4t.

Asset under management, which signified customer trust, topped R2,511.91b. Further, the solvency ratio was recorded at 208.9%, way above the minimum regulatory requirement of 150%.

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.